Last updated on September 2017

A phase 2A, randomized, double-blind, placebo-controoled, study to evaluate safety and efficacy of PF-06700841 in subjects with moderate to severe plaque psoriasis.


Other Details:

Study related visits and medication at no cost as well as compensation for time and travel.



Find a site near you

Start Over

Psoriasis Treatment Center of Central New Jersey

59 One Mile Road Extension East Windsor, NJ USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.